Global Perfluorodecalin for Ophthalmic Surgery 麻豆原创 Growth 2024-2030

Publication ID:

LPI07245151

Publication Date:

July 17, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Perfluorodecalin for ophthalmic surgery is a perfluorocarbon aromatic organic compound. At room temperature, it is a colorless, odorless, non-toxic liquid with a low boiling point and a high boiling point. It can be used to fix and protect the eyeball during ophthalmic surgery.
The global Perfluorodecalin for Ophthalmic Surgery market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧erfluorodecalin for Ophthalmic Surgery Industry Forecast鈥� looks at past sales and reviews total world Perfluorodecalin for Ophthalmic Surgery sales in 2023, providing a comprehensive analysis by region and market sector of projected Perfluorodecalin for Ophthalmic Surgery sales for 2024 through 2030. With Perfluorodecalin for Ophthalmic Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perfluorodecalin for Ophthalmic Surgery industry.
This Insight Report provides a comprehensive analysis of the global Perfluorodecalin for Ophthalmic Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perfluorodecalin for Ophthalmic Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Perfluorodecalin for Ophthalmic Surgery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perfluorodecalin for Ophthalmic Surgery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perfluorodecalin for Ophthalmic Surgery.
United States market for Perfluorodecalin for Ophthalmic Surgery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Perfluorodecalin for Ophthalmic Surgery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Perfluorodecalin for Ophthalmic Surgery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Perfluorodecalin for Ophthalmic Surgery players cover Alchimia srl, Bausch + Lomb, BVI Medical, Geuder AG, Pharmpur, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Perfluorodecalin for Ophthalmic Surgery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 鈮� 95%
Purity 鈮� 97%
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alchimia srl
Bausch + Lomb
BVI Medical
Geuder AG
Pharmpur
Toomac Ophthalmic
Micromed srl
Key Questions Addressed in this Report
What is the 10-year outlook for the global Perfluorodecalin for Ophthalmic Surgery market?
What factors are driving Perfluorodecalin for Ophthalmic Surgery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Perfluorodecalin for Ophthalmic Surgery market opportunities vary by end market size?
How does Perfluorodecalin for Ophthalmic Surgery break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Perfluorodecalin for Ophthalmic Surgery by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Perfluorodecalin for Ophthalmic Surgery by Country/Region, 2019, 2023 & 2030
2.2 Perfluorodecalin for Ophthalmic Surgery Segment by Type
2.2.1 Purity 鈮� 95%
2.2.2 Purity 鈮� 97%
2.3 Perfluorodecalin for Ophthalmic Surgery Sales by Type
2.3.1 Global Perfluorodecalin for Ophthalmic Surgery Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Perfluorodecalin for Ophthalmic Surgery Sale Price by Type (2019-2024)
2.4 Perfluorodecalin for Ophthalmic Surgery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Perfluorodecalin for Ophthalmic Surgery Sales by Application
2.5.1 Global Perfluorodecalin for Ophthalmic Surgery Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Perfluorodecalin for Ophthalmic Surgery Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Perfluorodecalin for Ophthalmic Surgery Breakdown Data by Company
3.1.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales by Company (2019-2024)
3.1.2 Global Perfluorodecalin for Ophthalmic Surgery Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue by Company (2019-2024)
3.2.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Company (2019-2024)
3.2.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Perfluorodecalin for Ophthalmic Surgery Sale Price by Company
3.4 Key Manufacturers Perfluorodecalin for Ophthalmic Surgery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Perfluorodecalin for Ophthalmic Surgery Product Location Distribution
3.4.2 Players Perfluorodecalin for Ophthalmic Surgery Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Perfluorodecalin for Ophthalmic Surgery by Geographic Region
4.1 World Historic Perfluorodecalin for Ophthalmic Surgery 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Perfluorodecalin for Ophthalmic Surgery 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales by Country/Region (2019-2024)
4.2.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue by Country/Region (2019-2024)
4.3 Americas Perfluorodecalin for Ophthalmic Surgery Sales Growth
4.4 APAC Perfluorodecalin for Ophthalmic Surgery Sales Growth
4.5 Europe Perfluorodecalin for Ophthalmic Surgery Sales Growth
4.6 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales Growth
5 Americas
5.1 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Country
5.1.1 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Country (2019-2024)
5.1.2 Americas Perfluorodecalin for Ophthalmic Surgery Revenue by Country (2019-2024)
5.2 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Type (2019-2024)
5.3 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Region
6.1.1 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Region (2019-2024)
6.1.2 APAC Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2019-2024)
6.2 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Type (2019-2024)
6.3 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Perfluorodecalin for Ophthalmic Surgery by Country
7.1.1 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Country (2019-2024)
7.1.2 Europe Perfluorodecalin for Ophthalmic Surgery Revenue by Country (2019-2024)
7.2 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Type (2019-2024)
7.3 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery by Country
8.1.1 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales by Country (2019-2024)
8.1.2 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Revenue by Country (2019-2024)
8.2 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales by Type (2019-2024)
8.3 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Perfluorodecalin for Ophthalmic Surgery
10.3 Manufacturing Process Analysis of Perfluorodecalin for Ophthalmic Surgery
10.4 Industry Chain Structure of Perfluorodecalin for Ophthalmic Surgery
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Perfluorodecalin for Ophthalmic Surgery Distributors
11.3 Perfluorodecalin for Ophthalmic Surgery Customer
12 World Forecast Review for Perfluorodecalin for Ophthalmic Surgery by Geographic Region
12.1 Global Perfluorodecalin for Ophthalmic Surgery 麻豆原创 Size Forecast by Region
12.1.1 Global Perfluorodecalin for Ophthalmic Surgery Forecast by Region (2025-2030)
12.1.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Perfluorodecalin for Ophthalmic Surgery Forecast by Type (2025-2030)
12.7 Global Perfluorodecalin for Ophthalmic Surgery Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Alchimia srl
13.1.1 Alchimia srl Company Information
13.1.2 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.1.3 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Alchimia srl Main Business Overview
13.1.5 Alchimia srl Latest Developments
13.2 Bausch + Lomb
13.2.1 Bausch + Lomb Company Information
13.2.2 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.2.3 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bausch + Lomb Main Business Overview
13.2.5 Bausch + Lomb Latest Developments
13.3 BVI Medical
13.3.1 BVI Medical Company Information
13.3.2 BVI Medical Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.3.3 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 BVI Medical Main Business Overview
13.3.5 BVI Medical Latest Developments
13.4 Geuder AG
13.4.1 Geuder AG Company Information
13.4.2 Geuder AG Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.4.3 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Geuder AG Main Business Overview
13.4.5 Geuder AG Latest Developments
13.5 Pharmpur
13.5.1 Pharmpur Company Information
13.5.2 Pharmpur Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.5.3 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pharmpur Main Business Overview
13.5.5 Pharmpur Latest Developments
13.6 Toomac Ophthalmic
13.6.1 Toomac Ophthalmic Company Information
13.6.2 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.6.3 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Toomac Ophthalmic Main Business Overview
13.6.5 Toomac Ophthalmic Latest Developments
13.7 Micromed srl
13.7.1 Micromed srl Company Information
13.7.2 Micromed srl Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications
13.7.3 Micromed srl Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Micromed srl Main Business Overview
13.7.5 Micromed srl Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.